Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion
- 1 June 2008
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 44 (6) , 595-600
- https://doi.org/10.1016/j.oraloncology.2007.08.016
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Successful treatment of an extensive verrucous carcinoma with topical 5‐aminolevulinic acid‐mediated photodynamic therapyJournal of Oral Pathology & Medicine, 2005
- Photodynamic Therapy of oral dysplasia with topical 5‐aminolevulinic acid and light‐emitting diode arrayLasers in Surgery and Medicine, 2004
- Photodynamic therapy (PDT) using topically applied δ‐aminolevulinic acid (ALA) for the treatment of oral leukoplakiaJournal of Oral Pathology & Medicine, 2003
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancersEuropean Archives of Oto-Rhino-Laryngology, 2001
- Treatment of oral leukoplakia by topical application of 5-aminolevulinic acidInternational Journal of Oral & Maxillofacial Surgery, 1998
- Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavityCancer, 1996
- Photodynamic Therapy (PDT) and Photodiagnosis (PD) Using Endogenous Photosensitization Induced by 5-Aminolevulinic Acid (ALA): Mechanisms and Clinical ResultsJournal of Clinical Laser Medicine & Surgery, 1996
- Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acidThe Lancet, 1993
- Photodynamic therapy with endogenous protoporphyrinJournal of Photochemistry and Photobiology B: Biology, 1990